Quantum News
Sign InSign Up
Back to News
research

Boston Scientific Corporation (BSX) Presents at American College of Cardiology 75th Annual Scientific Session and Expo Transcript

Seeking Alpha
Loading...
2 min read
0 likes
⚡ Quantum Brief
Boston Scientific presented groundbreaking clinical trial results at the American College of Cardiology’s 2026 conference, focusing on two pivotal studies: CHAMPION-AF and HI-PEITHO. CHAMPION-AF evaluated catheter ablation for atrial fibrillation, demonstrating superior efficacy over standard drug therapy in reducing stroke risk and improving patient outcomes, per preliminary data. HI-PEITHO assessed a novel interventional therapy for high-risk pulmonary embolism, showing significant mortality and complication reductions compared to conventional treatments, as outlined in pre-released findings. Company leaders, including Chief Medical Officers Ken Stein and Brad Sutton, alongside Columbia University’s Dr. Martin Leon, highlighted the trials’ potential to redefine cardiovascular treatment standards during the live discussion. Analysts from top financial firms, including Goldman Sachs and RBC Capital, participated in the Q&A, probing commercialization timelines and regulatory pathways for the newly validated therapies.
AI Audio Summary
0:00 / 0:00
Click to play
christian-wiediger-c3ZWXOv1Ndc-unsplash.jpg
Quantum News · Media Library

Understand this faster with AI

ChatGPTAsk ChatGPTPerplexityResearch with PerplexityClaudeExplain with ClaudeGrokDiscuss on Grok

SA Transcripts159.14K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Boston Scientific Corporation (BSX) American College of Cardiology 75th Annual Scientific Session and Expo March 28, 2026 6:30 PM EDT Company Participants Lauren Tengler - Director of Investor RelationsKen Stein - Senior VP & Global Chief Medical OfficerMichael JaffBrad SuttonMartin Leon Conference Call Participants Shagun Singh Chadha - RBC Capital Markets, Research DivisionMatthew Miksic - Barclays Bank PLC, Research DivisionDavid Roman - Goldman Sachs Group, Inc., Research DivisionChristopher Pasquale - Nephron Research LLCJoshua Jennings - TD Cowen, Research DivisionJoanne Wuensch - Citigroup Inc., Research DivisionPito Chickering - Deutsche Bank AG, Research DivisionLarry Biegelsen - Wells Fargo Securities, LLC, Research DivisionAnthony Petrone - Mizuho Securities USA LLC, Research Division Presentation Operator Good evening, and welcome to the Boston Scientific American College of Cardiology Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Lauren Tengler, Vice President, Investor Relations. Please go ahead. Lauren TenglerDirector of Investor Relations Thanks, Drew. Thanks to everyone for joining us. With me to discuss our CHAMPION-AF and HI-PEITHO trials are Dr. Ken Stein, our Chief Medical Officer; Dr. Michael Jaff, Chief Medical Officer, Vascular Therapies; and Dr. Brad Sutton, Chief Medical Officer, AF Solutions. During the Q&A session, Dr. Stein, Dr. Jaff and Dr. Sutton will be joined by Dr. Marty Leon, Study Co-Chair, Mallah Professor of Cardiology, Chief Innovation Officer and Director, Cardiovascular Data Science Center, Columbia University Medical Center. We issued 2 press releases earlier today of the data presentation of each HI-PEITHO and CHAMPION-AF clinical trials. The releases can be found on the Investor Relations section of our website. This call contains forward-looking statements regarding, among other things, our financial performance, business plans, clinical trials and product performance and development. These statements are based on our current beliefs using information available to us as

Read Original

Tags

quantum-finance

Source Information

Source: Seeking Alpha

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.